Idea for MRNA:
- Contrarian bet
- Investors believing that Nu variant will be a boon for Moderna and vaccine stocks.
- I think the opposite. Exit for Vaccine pump and dumpers before the bear market.
- Either the Nu var is a ruse, and we dont need boosters (bearish MRNA)
- Or Nu var is resistant to all vaccines (bearish MRNA)
Either way, very cheap to fade it right now.
Long 225P Dec 17 (1.00) debit
GLHF
- DPT
- Contrarian bet
- Investors believing that Nu variant will be a boon for Moderna and vaccine stocks.
- I think the opposite. Exit for Vaccine pump and dumpers before the bear market.
- Either the Nu var is a ruse, and we dont need boosters (bearish MRNA)
- Or Nu var is resistant to all vaccines (bearish MRNA)
Either way, very cheap to fade it right now.
Long 225P Dec 17 (1.00) debit
GLHF
- DPT
評論:
It's actually the Omicron variant not Nu
評論:
It looks like not only was my assessment correct, but I was correct in both cases at once.
South Africa claims the symptoms are 'mild'.
Moderna CEO: "Reduced effectiveness of vaccine for Omicron".
South Africa claims the symptoms are 'mild'.
Moderna CEO: "Reduced effectiveness of vaccine for Omicron".
交易結束：目標達成:
Closed for 3.00 credit, +200% gain, could go lower but looking for other opportunities now.
評論:
"I took a malicious pleasure in making money by selling short stocks that were institutional favorites." - George Soros